Brokerages Maintain Stance On Sun Pharma After Its Q2 Results
Dilip Shanghvi, managing director of Sun Pharmaceutical Industries Ltd. (Photographer: Kuni Takahashi/Bloomberg)

Brokerages Maintain Stance On Sun Pharma After Its Q2 Results

Most analysts maintained their stance on Sun Pharmaceutical Industries Ltd. after September quarter results of India’s largest drugmaker met estimates, aided by higher-than-expected sales in domest...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.